Skip to main content

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

  • Barclays Gene Editing & Gene Therapy Summit

    Date: Monday, November 15th at 10:30 a.m. Eastern Time
  • Stifel 2021 Virtual Healthcare Conference

    Date: Monday, November 15th at 3:20 p.m. Eastern Time
  • Jefferies London Healthcare Conference

    Date: Tuesday, November 16th at 8:40 a.m. Eastern Time

For presentations and fireside chats that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.